Literature DB >> 21969454

Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.

Romain Lefebvre1, Claude Legrand, Estela González-Rodríguez, Linda Groom, Robert T Dirksen, Vincent Jacquemond.   

Abstract

Mutations of the gene encoding the type 1 ryanodine receptor (RyR1) are associated with skeletal muscle disorders including malignant hyperthermia susceptibility (MHS) and central core disease (CCD). We used in vivo expression of EGFP-RyR1 constructs in fully differentiated mouse muscle fibres to characterize the function of several RyR1 mutants. Wild-type and Y523S, R615C, R2163H and I4897T mutants of RyR1 were separately expressed and found to be present within restricted regions of fibres with a pattern consistent with triadic localization. Confocal measurements of voltage-clamp-activated myoplasmic Ca(2+) transients demonstrated alterations of sarcoplasmic reticulum (SR) Ca(2+) release spatially correlated with the presence of exogenous RyR1s. The Y523S, R615C and R2163H RyR1 MHS-related mutants were associated with enhanced peak Ca(2+) release for low and moderate levels of depolarization, whereas the I4897T CCD mutant produced a chronic reduction of peak SR Ca(2+) release. For example, peak Ca(2+) release in response to a depolarization to -20 mV in regions of fibres expressing Y523S and I4897T was 2.0 ± 0.3 (n = 9) and 0.46 ± 0.1 (n = 5) times the corresponding value in adjacent, non-expressing regions of the same fibre, respectively. Interestingly no significant change in the estimated total amount of Ca(2+) released at the end of large depolarizing pulses was observed for any of the mutant RyR1 channels. Overall, results are consistent with an 'inherent' increase in RyR1 sensitivity to activation by the voltage sensor for the MHS-related RyR1 mutants and a partial failure of voltage-gated release for the CCD-related I4897T mutant, that occur with no sign of change in SR Ca(2+) content. Furthermore, the results indicate that RyR1 channel density is tightly regulated even under the present conditions of forced exogenous expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969454      PMCID: PMC3240878          DOI: 10.1113/jphysiol.2011.216408

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  49 in total

1.  Ca2+ release through ryanodine receptors regulates skeletal muscle L-type Ca2+ channel expression.

Authors:  G Avila; K M O'Connell; L A Groom; R T Dirksen
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

Review 2.  Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels?

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Trends Cardiovasc Med       Date:  2002-07       Impact factor: 6.677

Review 3.  Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.

Authors:  Alla D Lyfenko; Sanjeewa A Goonasekera; Robert T Dirksen
Journal:  Biochem Biophys Res Commun       Date:  2004-10-01       Impact factor: 3.575

4.  Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2001-09       Impact factor: 4.086

5.  Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.

Authors:  B Dietze; J Henke; H M Eichinger; F Lehmann-Horn; W Melzer
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

6.  Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.

Authors:  Tianzhong Yang; Tram Anh Ta; Isaac N Pessah; Paul D Allen
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

7.  Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.

Authors:  Sylvie Ducreux; Francesco Zorzato; Clemens Müller; Caroline Sewry; Francesco Muntoni; Ros Quinlivan; Gabriella Restagno; Thierry Girard; Susan Treves
Journal:  J Biol Chem       Date:  2004-08-08       Impact factor: 5.157

Review 8.  Calcium signaling in isolated skeletal muscle fibers investigated under "Silicone Voltage-Clamp" conditions.

Authors:  Claude Collet; Sandrine Pouvreau; Laszlo Csernoch; Bruno Allard; Vincent Jacquemond
Journal:  Cell Biochem Biophys       Date:  2004       Impact factor: 2.194

9.  Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.

Authors:  M R Davis; E Haan; H Jungbluth; C Sewry; K North; F Muntoni; T Kuntzer; P Lamont; A Bankier; P Tomlinson; A Sánchez; P Walsh; L Nagarajan; C Oley; A Colley; A Gedeon; R Quinlivan; J Dixon; D James; C R Müller; N G Laing
Journal:  Neuromuscul Disord       Date:  2003-02       Impact factor: 4.296

10.  The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.

Authors:  Guillermo Avila; Kristen M S O'Connell; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2003-03-17       Impact factor: 4.086

View more
  11 in total

1.  Overexpression of ryanodine receptor type 1 enhances mitochondrial fragmentation and Ca2+-induced ATP production in cardiac H9c2 myoblasts.

Authors:  Jin O-Uchi; Bong Sook Jhun; Stephen Hurst; Sara Bisetto; Polina Gross; Ming Chen; Sarah Kettlewell; Jongsun Park; Hideto Oyamada; Godfrey L Smith; Takashi Murayama; Shey-Shing Sheu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-11       Impact factor: 4.733

2.  Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice.

Authors:  Candice Kutchukian; Mirella Lo Scrudato; Yves Tourneur; Karine Poulard; Alban Vignaud; Christine Berthier; Bruno Allard; Michael W Lawlor; Ana Buj-Bello; Vincent Jacquemond
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

3.  Molecular mechanism of the severe MH/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM.

Authors:  Kavita A Iyer; Yifan Hu; Thomas Klose; Takashi Murayama; Montserrat Samsó
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779

Review 4.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

5.  Impaired excitation-contraction coupling in muscle fibres from the dynamin2R465W mouse model of centronuclear myopathy.

Authors:  Candice Kutchukian; Peter Szentesi; Bruno Allard; Delphine Trochet; Maud Beuvin; Christine Berthier; Yves Tourneur; Pascale Guicheney; Laszlo Csernoch; Marc Bitoun; Vincent Jacquemond
Journal:  J Physiol       Date:  2017-11-21       Impact factor: 5.182

6.  Depression of voltage-activated Ca2+ release in skeletal muscle by activation of a voltage-sensing phosphatase.

Authors:  Christine Berthier; Candice Kutchukian; Clément Bouvard; Yasushi Okamura; Vincent Jacquemond
Journal:  J Gen Physiol       Date:  2015-04       Impact factor: 4.086

7.  Dietary selenium augments sarcoplasmic calcium release and mechanical performance in mice.

Authors:  Dóra Bodnár; Olga Ruzsnavszky; Tamás Oláh; Beatrix Dienes; Ildikó Balatoni; Éva Ungvári; Ilona Benkő; Beáta Babka; József Prokisch; László Csernoch; Péter Szentesi
Journal:  Nutr Metab (Lond)       Date:  2016-11-03       Impact factor: 4.169

Review 8.  Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Authors:  Tokunbor A Lawal; Emily S Wires; Nancy L Terry; James J Dowling; Joshua J Todd
Journal:  Orphanet J Rare Dis       Date:  2020-05-07       Impact factor: 4.123

9.  Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.

Authors:  Romain Lefebvre; Claude Legrand; Linda Groom; Robert T Dirksen; Vincent Jacquemond
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

10.  Tracking the sarcoplasmic reticulum membrane voltage in muscle with a FRET biosensor.

Authors:  Colline Sanchez; Christine Berthier; Bruno Allard; Jimmy Perrot; Clément Bouvard; Hidekazu Tsutsui; Yasushi Okamura; Vincent Jacquemond
Journal:  J Gen Physiol       Date:  2018-06-13       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.